TGF-β inhibitors for the treatment of cancer

被引：65
|
作者：
Lahn, M [1 ]
Kloeker, S [1 ]
Berry, BS [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Therapeut Area Oncol, Indianapolis, IN 46285 USA
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2005年 / 14卷 / 06期
关键词：
antisense oligonucleotide; cancer; clinical Studies; knockout mice; monoclonal antibodies; TGF-beta; TGF-beta RI kinase inhibitors;
D O I：
10.1517/13543784.14.6.629
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Advances in understanding the role of transforming growth factor (TGF)-beta in tumorigenesis have led to the development of TGF-beta inhibitors for cancer treatment. Three platforms of TGF-beta inhibitors have evolved: antisense oligonucleotides, monoclonal antibodies and small molecules. in this review, the current stage of development of each known TGF-beta inhibitor will be discussed. As part of the risk/benefit assessment of TGF-beta inhibitors, the known effects of TGF-beta deficiency in mice, non-clinical toxicology studies with TGF-beta inhibitors in rats, and the clinical studies with monoclonal antibodies against TGF-beta will be summarised.
引用
收藏
页码：629 / 641
页数：13
相关论文
共 50 条
  • [21] The emerging role of TGF-β superfamily coreceptors in cancer
    Bernabeu, Carmelo
    Lopez-Novoa, Jose M.
    Quintanilla, Miguel
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (10): : 954 - 973
  • [22] Crosstalk between TGF-β and hedgehog signaling in cancer
    Javelaud, Delphine
    Pierrat, Marie-Jeanne
    Mauviel, Alain
    FEBS LETTERS, 2012, 586 (14) : 2016 - 2025
  • [23] TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
    Caja, Laia
    Dituri, Francesco
    Mancarella, Serena
    Caballero-Diaz, Daniel
    Moustakas, Aristidis
    Giannelli, Gianluigi
    Fabregat, Isabel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [24] TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Marcus A. Alvarez
    Júlia Pedó Freitas
    S. Mazher Hussain
    Evan S. Glazer
    Journal of Gastrointestinal Cancer, 2019, 50 : 207 - 213
  • [25] Inhibitors/antagonists of TGF-β system in kidney fibrosis
    Yanagita, Motoko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (10) : 3686 - 3691
  • [26] TGF-β expression in vulvar cancer
    Karon, Przemyslaw
    Olejek, Anita
    Olszak-Wasik, Katarzyna
    GINEKOLOGIA POLSKA, 2014, 85 (11) : 847 - 851
  • [27] TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
    Park, Cheol Ho
    Yoo, Tae-Hyun
    PHARMACEUTICALS, 2022, 15 (12)
  • [28] Stromal Modulators of TGF-β in Cancer
    Costanza, Brunella
    Umelo, Ijeoma Adaku
    Bellier, Justine
    Castronovo, Vincent
    Turtoi, Andrei
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (01)
  • [29] Identification of Inhibitors of Thrombospondin 1 Activation of TGF-β
    Suto, Mark J.
    Gupta, Vandana
    Mathew, Bini
    Zhang, Wei
    Pallero, Manuel A.
    Murphy-Ullrich, Joanne E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06): : 1130 - 1136
  • [30] Investigation of the Effects of TGF- β and TGF- β Inhibitors on Cell Proliferation and Senescence in Human Corneal Endothelial Cells
    Ozen, Ebru Avci
    Toprak, Emine Kilic
    Donmez, Aysegul Cort
    Toprak, Ibrahim
    ACTA PHYSIOLOGICA, 2023, 237 : 25 - 25
12345